Epo is administered 1000 U/kg, iv in 48 hours after premature birth, and at 48 hours interval for 3 doses per week. After 6 doses, Subcutaneously 3 doses per week until at corrected age of 34 weeks.

Normal saline is administered 5ml, iv at 3 to 6 hours after premature birth, and at 48 hours interval for 3 doses per week. After 6 doses, Subcutaneously 3 doses per week until at corrected age of 34 weeks.

Premature Infant

Epo is administered 1000 U/kg, iv in 48 hours after premature birth, and at 48 hours interval for 3 doses per week. After 6 doses, subcutaneously 400 U/Kg per injection and 3 doses per week until at corrected age of 34 weeks.

Normal saline

Children Hospital of Fudan University

Erythropoietin in Premature Infants to Prevent Encephalopathy

Erythropoietin in Premature Infants to Prevent Encephalopathy: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Erythropoietin in China

To evaluate neurodevelopmental function via Bayley Scores of Infant Development Mental Development Index (BSID) and gain incidence of MDI<70(Severe) or MDI<85(Moderate).

To gain changes in standardized gross motor function using GMFM (Gross Motor Function Measure) as a standardized measurement tool for assessing Gross Motor Function consisting of sub-scales, lying & rolling, sitting, crawling & kneeling, standing, walking, running & jumping (range: 0~100 , Higher value means better gross motor function).

To compare changes in brain as measured by MRI in Epo treatment and control groups at 9 months.

To compare changes in brain as measured by MRI in Epo treatment and control groups at 18 months.

To compare changes in brain electrophysiology by SSEP at 36 weeks.

To compare changes in brain electrophysiology by SSEP at 18 months.

To compare changes in brain electrophysiology by VEP at 36 weeks.

To compare changes in brain electrophysiology by VEP at 18 months.

To compare changes in brain electrophysiology by BAER at 36 weeks.

To compare changes in brain electrophysiology by BAER at 18 months.

To gain the incidence of Polycythemia, neutropenia, thrombocytopenia, hypertension, sepsis, intraventricular hemorrhage(IVH), periventricular leukomalacia(PVL), seizure, necrotizing enterocolitis (NEC), persistent ductus arterious (PDA), apnea of prematurity, pulmonary haemorrhage, pulmonary hypertension, Prolonged blood coagulation time, retinopathy of prematurity(ROP), cardiac arrhythmia, major venous thrombosis, Renal failure treated with dialysis, pneumonia, pulmonary airleak and chronic lung disease.

Biomarkers for Oxidative Stress, Inflammation and immune response as a measure of efficacy of erythropoietin for hypoxic ischemic encephalopathy.

polycythemia/seizures

Erythropoietin in Premature Infants to Prevent Encephalopathy

Craniofacial Surgery Perioperative Registry

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus